Cargando…
Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis
Pulmonary fibrosis is a devastating disease, in which fibrotic tissue progressively replaces lung alveolar structure, resulting in chronic respiratory failure. Alveolar type II cells act as epithelial stem cells, being able to transdifferentiate into alveolar type I cells, which mediate gas exchange...
Autores principales: | Volpe, Maria Concetta, Ciucci, Giulio, Zandomenego, Giulia, Vuerich, Roman, Ring, Nadja Anneliese Ruth, Vodret, Simone, Salton, Francesco, Marchesan, Pietro, Braga, Luca, Marcuzzo, Thomas, Bussani, Rossana, Colliva, Andrea, Piazza, Silvano, Confalonieri, Marco, Zacchigna, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349845/ https://www.ncbi.nlm.nih.gov/pubmed/37454154 http://dx.doi.org/10.1038/s41419-023-05962-2 |
Ejemplares similares
-
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation
por: Ring, Nadja Anneliese Ruth, et al.
Publicado: (2021) -
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation
por: Moimas, Silvia, et al.
Publicado: (2019) -
Immune Cell Therapies to Improve Regeneration and Revascularization of Non-Healing Wounds
por: Groppa, Elena, et al.
Publicado: (2020) -
Mechanisms of ATII-to-ATI Cell Differentiation during Lung Regeneration
por: Aspal, Mohit, et al.
Publicado: (2020) -
Persistent SARS‐CoV‐2 infection in patients seemingly recovered from COVID‐19
por: Bussani, Rossana, et al.
Publicado: (2023)